- SK Capital Partners has completed its acquisition of LISI Group’s Medical division, rebranding the business as Precera Medical with headquarters in Big Lake, Minnesota.
- The newly independent CDMO will serve global medical device OEMs with expanded leadership and a focus on high-precision manufacturing.
SK Capital Partners, a New York-based private investment firm specialising in the life sciences, ingredients, and specialty materials sectors, has completed its previously announced acquisition of LISI Group’s Medical division. The business, now renamed Precera Medical, has established its headquarters in Big Lake, Minnesota, marking its transition into an independent contract development and manufacturing organisation (CDMO) for medical device OEMs and innovators. LISI Group will retain a minority stake in the company.
Precera Medical will focus on producing high-precision components and assemblies for global medical device manufacturers. The company operates four manufacturing sites—two in Minnesota and two in France—offering expertise in development, rapid prototyping, precision machining, forging, and automated production.
As part of the transition, the company has appointed Dylan Hushka as Chief Executive Officer. Hushka previously served as President of DuPont’s healthcare CDMO business and held leadership roles at Spectrum Plastics Group, Nordson Medical, and Medtronic. Barry Lederman joins as Chief Financial Officer, bringing experience from Worldwide Clinical Trials and other SK Capital portfolio companies.
“I am proud to join the Precera Medical team and, as a former customer, have been impressed by Precera’s world-class engineering, manufacturing, automation, quality assurance, and customer focus. This is a new era of precision manufacturing defined by speed, reliability, and uncompromising quality.”
Dylan Hushka, CEO of Precera Medical
To guide its strategic growth, Precera Medical has established an advisory board featuring industry leaders, including Chris Qualters, Art Burghouwt, and Brian Hutchison, alongside representatives from SK Capital and LISI Group. Josh Lieberman, Principal at SK Capital, said the firm plans to support investment in new capacity and expanded capabilities through both organic growth and acquisitions.
